Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Berberine regulates endocrine function in mice with polycystic ovary syndrome through PI3K/Akt/GSK-3? insulin signaling pathway

Dan Gao, Yaxin Liu

Department of Gynecology and Obstetrics, Wuxi No. 2 People’s Hospital (North Courtyard), Wuxi 214000, Jiangsu Province, China;

For correspondence:- Yaxin Liu Email: liuyaxin6888@163.com

Accepted: 31 August 2022 Published: 30 September 2022

Citation: Gao D, Liu Y. Berberine regulates endocrine function in mice with polycystic ovary syndrome through PI3K/Akt/GSK-3? insulin signaling pathway. Trop J Pharm Res 2022; 21(9):1823-1828 doi: 10.4314/tjpr.v21i9.2

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the influence of berberine on endocrine status in mice with polycystic ovary syndrome (PCOS), and the underlying mechanism of action.

Methods: A total of 80 mice were used in this research. Sixteen mice were randomly selected to serve as control. The remaining 64 mice were subcutaneously given dehydroepiandrosterone (DHEA) injection to establish a mouse model of PCOS. The PCOS mice were randomly divided into model group, and low-dose-, medium-dose and high-dose berberine groups. Oral glucose tolerance test (OGTT) and expression levels of PI3K/Akt/GSK-3 signaling pathway related proteins (PI3K 85, Akt2, p-GSK-3 Tyr216, p-GSK-3β Ser9, and GSK-3) were evaluated.

Results: At 60 and 120 min, OGTT blood glucose level of model group was significantly higher than that of blank control group, but it was significantly lower in the berberine dose groups than in model group (p < 0.05). There were significantly higher protein expression levels of pi3k85, AKT2 and p-GSK-3β tyr116 in berberine dose groups than in model mice, but the protein levels of p-GSK-3β ser9 in berberine dose groups were significantly lower than that in model mice.

Conclusion: Berberine improved endocrine function in PCOS mice through a mechanism involving regulation of the key proteins of PI3K/Akt/GSK-3 β insulin signaling pathway. Thus, berberine may potentially play a similar role in humans with PCOS functions. However, clinical trials need to be carried out first.

Keywords: Polycystic ovary syndrome, PCOS, Berberine, PI3K, Akt, GSK-β